Literature DB >> 8698036

Applications of the monitoring process model to coping with severe long-term medical threats.

S M Miller1, M Rodoletz, C E Mangan, C M Schroeder, T V Sedlacek.   

Abstract

Guided by the monitoring process model (MPM), the authors explored the illness responses of 2 samples: high monitors (who are cognitively vigilant to and amplify threat-related cues) and low monitors (who avoid them and blunt their impact). Both samples-101 women with human papillomavirus-related precancerous cervical dysplasia and 75 HIV-infected gay men-were undergoing long-term medical follow-up and management. Structural equation analysis showed an adequate fit of the MPM to the data within each sample, supporting the model's heuristic value: High monitors experienced greater disease-related intrusive ideation, which triggered greater avoidant ideation to forestall panic, particularly in the more threatened HIV-positive sample. However, efforts to avoid disturbing intrusive thoughts were ineffective, requiring increasingly extreme defensive strategies (i.e., denial and mental and behavioral disengagement).

Entities:  

Mesh:

Year:  1996        PMID: 8698036     DOI: 10.1037//0278-6133.15.3.216

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  23 in total

1.  Theories for practitioners: two frameworks for studying consumer health information-seeking behavior.

Authors:  L M Baker; K E Pettigrew
Journal:  Bull Med Libr Assoc       Date:  1999-10

2.  Matching intra-procedural information with coping style reduces psychophysiological arousal in women undergoing colposcopy.

Authors:  Susanna Kola; Jane C Walsh; Brian M Hughes; Siobhán Howard
Journal:  J Behav Med       Date:  2012-06-24

3.  Identification of cognitive profiles among women considering BRCA1/2 testing through the utilisation of cluster analytic techniques.

Authors:  Pagona Roussi; Kerry A Sherman; Suzanne M Miller; Karen Hurley; Mary B Daly; Andrew Godwin; Joanne S Buzaglo; Kuang-Yi Wen
Journal:  Psychol Health       Date:  2011-07-14

4.  Predictors of adherence to follow-up recommendations after an abnormal Pap smear among underserved inner-city women.

Authors:  Suzanne M Miller; Erin K Tagai; Kuang-Yi Wen; Minsun Lee; Siu-Kuen Azor Hui; Deirdre Kurtz; John Scarpato; Enrique Hernandez
Journal:  Patient Educ Couns       Date:  2017-01-31

5.  Tailoring messages to individual differences in monitoring-blunting styles to increase fruit and vegetable intake.

Authors:  Pamela Williams-Piehota; Amy E Latimer; Nicole A Katulak; Ashley Cox; Stephanie A N Silvera; Linda Mowad; Peter Salovey
Journal:  J Nutr Educ Behav       Date:  2009 Nov-Dec       Impact factor: 3.045

Review 6.  Treating perioperative anxiety and pain in children: a tailored and innovative approach.

Authors:  Michelle A Fortier; Zeev N Kain
Journal:  Paediatr Anaesth       Date:  2014-09-30       Impact factor: 2.556

7.  Testing messages to encourage discussion of clinical trials among cancer survivors and their physicians: examining monitoring style and message detail.

Authors:  Lindsay R Duncan; Amy E Latimer; Elizabeth Pomery; Susan E Rivers; Michelle C Berotoli; Peter Salovey
Journal:  J Cancer Educ       Date:  2013-03       Impact factor: 2.037

Review 8.  Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?

Authors:  Donna M Evon; Carol E Golin; Michael W Fried; Francis J Keefe
Journal:  J Consult Clin Psychol       Date:  2012-06-25

9.  The role of monitoring in determining quality of life following treatment for a bone tumor.

Authors:  C Eiser; P Cool; R Grimer; S Carter; A Ellis; S Kopel; J R Eiser
Journal:  Int J Behav Med       Date:  1997

10.  Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.

Authors:  S Manne; D Kashy; T Albrecht; Y-N Wong; A Lederman Flamm; A B Benson; S M Miller; Linda Fleisher; J Buzaglo; N Roach; M Katz; E Ross; M Collins; D Poole; S Raivitch; D M Miller; T G Kinzy; T Liu; N J Meropol
Journal:  Eur J Cancer Care (Engl)       Date:  2014-01-28       Impact factor: 2.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.